Radiolabelled monoclonal antibodies in oncology. III. Radioimmunotherapy.
The requirements, problems and progress of radioimmunotherapy in the management of certain malignancies are described. The future prospects using a two- or three-stage approach are promising.
Britton
K E
KE
St Bartholomew's Hospital Medical College, London, UK.
Mather
S J
SJ
Granowska
M
M
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000951:Antigens, Neoplasm / Q000276:immunology*; D003131:Combined Modality Therapy; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000628:therapy*; D011868:Radioisotopes / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D011868:Radioisotopes